Symbiox Investment & Trading Co Ltd
Symbiox Investment & Trading Co Ltd (SYMBIOX): company summary
The company's business has declined over the past year, with revenue falling 42.0% to ₹2 crore.
Symbiox Investment & Trading Co Ltd (SYMBIOX) is a micro-cap Financial Services company valued at ₹5 crore operating in Other Financial Services on the NSE and BSE.
- Recent price move
- Symbiox Investment & Trading Co Ltd last traded at ₹1.52, down 3.80% on the day.
- Financial performance
- The company's business has declined over the past year, with revenue falling 42.0% to ₹2 crore. The latest quarter saw revenue remain at ₹0 crore, while net profit stayed at ₹0 crore, though the quarter's net profit change versus the same quarter a year earlier was flat at +14.3%.
- Valuation multiples
- The stock trades at 21.7 times earnings, broadly in line with the Financial Services median of 19.3, 0.20 times book value.
- Things to watch
- The company has reported zero net profit for the latest fiscal year and the latest quarter, despite a slight increase in the net profit margin to 9.4%. The stock is 47.3% below its 52-week high, and revenue has declined significantly over the past three years, with a compound annual growth rate of -26.3%.
- Where it stands
- The company remains unprofitable, with zero net profit for the latest fiscal year and the latest quarter. The stock is trading at 47.3% below its 52-week high, and revenue has declined sharply over the past three years, with no improvement in profitability despite a rise in the net profit margin.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by valuation (8.5) and risk (7.4), but held back by momentum (0.0). Valuation looks strong at 8.5, but that is offset by momentum at 0.0 and quality at 2.9. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profitable in all of the last 5 years
- Profit compounding 16% a year
- Revenue shrinking 5% a year
- Momentum is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Financial Services stocks · Other Financial Services
Explore Symbiox Investment & Trading Co Ltd’s valuation
Free deep-dive tools · no sign-up
Symbiox Investment & Trading Co Ltd peers in Financial Services
Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.
Compare Symbiox Investment & Trading Co Ltd with peers
Related tools & concepts
Value Symbiox Investment & Trading Co Ltd with the ratios and calculators DocStoX uses in its analysis.

